Thermo Fisher Scientific Inc.

Symbol: TMO

NYSE

571.56

USD

Market price today

  • 36.5875

    P/E Ratio

  • 11.3421

    PEG Ratio

  • 217.94B

    MRK Cap

  • 0.00%

    DIV Yield

Thermo Fisher Scientific Inc. (TMO) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.41%

Operating Profit Margin

0.17%

Net Profit Margin

0.14%

Return on Assets

0.06%

Return on Equity

0.13%

Return on Capital Employed

0.08%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO:Mr. Marc N. Casper
Full-time employees:122000
City:Waltham
Address:168 Third Avenue
IPO:1980-03-17
CIK:0000097745

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

General Outlook

When we look at how much money they make before expenses, they keep 0.412% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.165%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.142%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.062% return, is a testament to Thermo Fisher Scientific Inc.'s adeptness in optimizing resource deployment. Thermo Fisher Scientific Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.133%. Furthermore, the proficiency of Thermo Fisher Scientific Inc. in capital utilization is underscored by a remarkable 0.084% return on capital employed.

Stock Prices

Thermo Fisher Scientific Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $581.9, while its low point bottomed out at $568.4. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Thermo Fisher Scientific Inc.'s stock market.

Liquidity Ratios

Analyzing TMO liquidity ratios reveals its financial health of the firm. The current ratio of 169.62% gauges short-term asset coverage for liabilities. The quick ratio (119.18%) assesses immediate liquidity, while the cash ratio (39.51%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio169.62%
Quick Ratio119.18%
Cash Ratio39.51%

Profitability Ratios

TMO profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 15.35% underscores its earnings before tax deductions. The effective tax rate stands at 3.88%, revealing its tax efficiency. The net income per EBT, 92.49%, and the EBT per EBIT, 92.99%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 16.51%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin15.35%
Effective Tax Rate3.88%
Net Income per EBT92.49%
EBT per EBIT92.99%
EBIT per Revenue16.51%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.70, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding119
Days of Inventory Outstanding75
Operating Cycle155.32
Days of Payables Outstanding37
Cash Conversion Cycle118
Receivables Turnover4.54
Payables Turnover9.78
Inventory Turnover4.87
Fixed Asset Turnover4.56
Asset Turnover0.44

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 23.37, and free cash flow per share, 19.79, depict cash generation on a per-share basis. The cash per share value, 19.00, showcases liquidity position. A payout ratio of 0.09 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.21, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share23.37
Free Cash Flow per Share19.79
Cash per Share19.00
Payout Ratio0.09
Operating Cash Flow Sales Ratio0.21
Free Cash Flow to Operating Cash Flow Ratio0.85
Cash Flow Coverage Ratio0.25
Short Term Coverage Ratio2.01
Capital Expenditure Coverage Ratio6.53
Dividend Paid and Capex Coverage Ratio4.68

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 36.67%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.78, we discern the balance between debt and equity financing. The long-term debt to capitalization, 40.64%, and total debt to capitalization, 43.89%, ratios shed light on its capital structure. An interest coverage of 10.66 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio36.67%
Debt Equity Ratio0.78
Long Term Debt to Capitalization40.64%
Total Debt to Capitalization43.89%
Interest Coverage10.66
Cash Flow to Debt Ratio0.25
Company Equity Multiplier2.13

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 111.03, provides a glimpse into top-line earnings distributed across each share. Net income per share, 15.53, reflects the portion of profit attributed to each share. The book value per share, 121.05, represents the net asset value distributed per share, while the tangible book value per share, -35.88, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share111.03
Net Income Per Share15.53
Book Value Per Share121.05
Tangible Book Value Per Share-35.88
Shareholders Equity Per Share121.05
Interest Debt Per Share94.02
Capex Per Share-3.83

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -4.58%, indicates top-line expansion, while the gross profit growth, -21.93%, reveals profitability trends. EBIT growth, -12.81%, and operating income growth, -12.81%, offer insights into operational profitability progression. The net income growth, -13.74%, showcases bottom-line expansion, and the EPS growth, -12.41%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-4.58%
Gross Profit Growth-21.93%
EBIT Growth-12.81%
Operating Income Growth-12.81%
Net Income Growth-13.74%
EPS Growth-12.41%
EPS Diluted Growth-12.41%
Weighted Average Shares Growth-1.53%
Weighted Average Shares Diluted Growth-1.52%
Dividends per Share Growth16.73%
Operating Cash Flow Growth-8.17%
Free Cash Flow Growth0.23%
10-Year Revenue Growth per Share205.60%
5-Year Revenue Growth per Share83.24%
3-Year Revenue Growth per Share36.47%
10-Year Operating CF Growth per Share290.23%
5-Year Operating CF Growth per Share92.70%
3-Year Operating CF Growth per Share4.04%
10-Year Net Income Growth per Share339.48%
5-Year Net Income Growth per Share112.51%
3-Year Net Income Growth per Share-3.52%
10-Year Shareholders Equity Growth per Share158.74%
5-Year Shareholders Equity Growth per Share76.40%
3-Year Shareholders Equity Growth per Share38.91%
10-Year Dividend per Share Growth per Share125.80%
5-Year Dividend per Share Growth per Share104.77%
3-Year Dividend per Share Growth per Share59.21%
Receivables Growth-12.79%
Inventory Growth-9.69%
Asset Growth1.62%
Book Value per Share Growth7.90%
Debt Growth1.24%
R&D Expense Growth-9.11%
SGA Expenses Growth-7.83%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 231,724,940,000, captures the company's total value, considering both debt and equity. Income quality, 1.40, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 61.47%, indicates the value of non-physical assets, and capex to operating cash flow, -17.59%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value231,724,940,000
Income Quality1.40
Research and Development to Revenue3.12%
Intangibles to Total Assets61.47%
Capex to Operating Cash Flow-17.59%
Capex to Revenue-3.45%
Capex to Depreciation-43.42%
Stock-Based Compensation to Revenue0.65%
Graham Number205.67
Return on Tangible Assets15.76%
Graham Net Net-90.93
Working Capital10,577,000,000
Tangible Asset Value-13,848,000,000
Net Current Asset Value-27,295,000,000
Invested Capital1
Average Receivables8,824,000,000
Average Payables3,126,500,000
Average Inventory5,361,000,000
Days Sales Outstanding70
Days Payables Outstanding38
Days of Inventory On Hand67
ROIC8.56%
ROE0.13%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 4.85, and the price to book ratio, 4.85, reflect the market's valuation relative to the company's book value. The price to sales ratio, 5.19, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 29.18, and price to operating cash flows, 24.73, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio4.85
Price to Book Ratio4.85
Price to Sales Ratio5.19
Price Cash Flow Ratio24.73
Price Earnings to Growth Ratio11.34
Enterprise Value Multiple18.56
Price Fair Value4.85
Price to Operating Cash Flow Ratio24.73
Price to Free Cash Flows Ratio29.18
Price to Tangible Book Ratio4.39
Enterprise Value to Sales5.41
Enterprise Value Over EBITDA21.61
EV to Operating Cash Flow27.57
Earnings Yield2.93%
Free Cash Flow Yield3.38%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Thermo Fisher Scientific Inc. (TMO) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 36.588 in 2024.

What is the ticker symbol of Thermo Fisher Scientific Inc. stock?

The ticker symbol of Thermo Fisher Scientific Inc. stock is TMO.

What is company IPO date?

IPO date of Thermo Fisher Scientific Inc. is 1980-03-17.

What is company current share price?

Current share price is 571.560 USD.

What is stock market cap today?

The market cap of stock today is 217942686720.000.

What is PEG ratio in 2024?

The current 11.342 is 11.342 in 2024.

What is the number of employees in 2024?

In 2024 the company has 122000.